Recombinetics (United States)
Recombinetics is a St. Paul, Minnesota-based bio-engineering company. The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the CEO. In November 2024, Recombinetics filed for Chapter 11 bankruptcy protection. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Recombinetics (United States), United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
74%
Total
Publications
182
Total Open
Publications
135
Total
Citations
6.6K
Open Access
Percentage
74%
Total
Publications
182
Total Open
Publications
135
Total
Citations
6.6K
Breakdown
Publisher Open
19%
Both
42%
Other Platform Open
13%
Closed
26%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 51%
57
Hybrid 35%
39
No Guarantees 14%
15
Other Platform Open
Domain 88%
89
Institution 25%
25
Preprint 13%
13
Public 9%
9
Other Internet 7%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 88 |
Europe PMC | Domain | 46 |
bioRxiv | Preprint | 13 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 10 |
Ecole Polytechnique Fédérale de Lausanne - Infoscience | Institution | 8 |
Semantic Scholar | Public | 7 |
DOI | Other Internet | 4 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Institution | 3 |
iastate.edu OAI-PMH Repository | Institution | 3 |
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna | Institution | 3 |